agonist-bound structure human p2y receptor 
p2y receptor p2yr one eight members p2yr family expressed humans one prominent clinical drug targets inhibition platelet aggregation although mutagenesis modelling studies p2yr provided useful insights ligand binding- agonist antagonist recognition function p2yr remain poorly understood molecular level report structures human p2yr complex full agonist methylthio-adenosine--diphosphate 2mesadp close analogue endogenous agonist adp angstrom resolution corresponding atp derivative methylthio-adenosine--triphosphate 2mesatp angstrom resolution structures together structure p2yr antagonist ethyl -benzylsulfonyl carbamoylpiperidin--yl--cyano--methylnicotinate azd1283 reveal striking conformational changes nucleotide non-nucleotide ligand complexes extracellular regions analysis changes provides insight distinct ligand binding landscape inthed-group class ag-protein-coupled receptors gpcrs agonist non-nucleotide antagonist adopt different orientations p2yr partially overlapped binding pockets agonist-bound p2yr structure answers long-standing questions surrounding p2yr-agonist recognition reveals interactions several residues reported involved agonist binding first example knowledge gpcr agonist access binding pocket requires large-scale rearrangements highly malleable extracellular region structural docking studies will therefore provide invaluable insight pharmacology mechanisms action agonists different classes antagonists p2yr potentially closely related p2yrs 
